Risk Factors Affect Long-Term Compliance to Coumadin Treatment (Self-Reporting)

Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of compliance to highly active antiretroviral therapy: Overview of published literature. J. Acquir. Immune Defic. Syndr., 31, 123-127.10.1097/00126334-200212153-0000712562034Search in Google Scholar

Anonymous (1994). Development of the WHOQOL: Rational and current status. Int. J. Mental Health, 23 (3), 24-56.Search in Google Scholar

Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines. Chest, 133, 160-198.10.1378/chest.08-067018574265Search in Google Scholar

Bushnell, C. D., Olson, D. M., Zhao, X., Pan, W., Zimmer, L. O., Goldstein, L. B., Alberts, M. J., Fagan, S. C., Fonarow, G. C., Johnston, S. C., Kidwell, C., LaBresh, K. A., Ovbiagele, B., Schwamm, L., Peterson, E. D. (2011). Secondary preventive medication persistence and compliance 1 year after stroke. Neurology, 77 (12), 1182-1190.10.1212/WNL.0b013e31822f0423326504721900638Search in Google Scholar

Chen, S. Y., Wu, N., Gulseth, M., LaMori, J., Bookhart, B. K., Boulanger, L., et al. (2013). One-year compliance to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. J. Manag. Care Pharm., 19 (4), 291-301.Search in Google Scholar

Deitelzweig, S. B, Lin, J., Kreilick, C., Hussein, M., Battleman, D. (2010). Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes. Adv. Ther., 27 (9), 623-633.10.1007/s12325-010-0056-z20680533Search in Google Scholar

DeWilde, S., Carey, I. M., Emmas, C., Richards, N., Cook, D. G. (2006). Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart, 92 (8), 1064-1070.10.1136/hrt.2005.069492186112416387813Search in Google Scholar

DiMatteo, M. R., Giordani, P. J., Lepper, H. S., Croghan, T. W. (2002). Patient compliance and medical treatment outcomes: A meta-analysis. Med. Care, 40 (9), 794-811.10.1097/00005650-200209000-0000912218770Search in Google Scholar

Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., Singer, D. E. (2010). Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ. Cardiovasc. Qual. Outcomes, 3 (6), 624-631.10.1161/CIRCOUTCOMES.110.937680306330520959565Search in Google Scholar

Ganz, D. A., Glynn, R. J., Mogun, H., Knight, E. L., Bohn, R. L., Avorn, J. (2000). Compliance to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J. Gen. Intern. Med., 15 (11), 776-781.10.1046/j.1525-1497.2000.91022.x149561311119169Search in Google Scholar

Haynes, R. B., McDonald, H. P., Garg, A. X. (2002). Helping patients follow prescribed treatment. J. Amer. Med. Assoc., 288 (22), 2880-2883.10.1001/jama.288.22.288012472330Search in Google Scholar

Hylek, E. M., Singer, D. E. (1994). Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann. Intern. Med., 120 (11), 897-902.10.7326/0003-4819-120-11-199406010-000018172435Search in Google Scholar

Hylek, E. M., Skates, S. J., Sheehan, M. A., Singer, D. E. (1996). An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New Engl. J. Med., 335 (8), 540-546.10.1056/NEJM1996082233508028678931Search in Google Scholar

Jackevicius, C. A., Mamdani, M., Tu, J. V. (2002). Compliance with statin therapy in elderly patients with and without acute coronary syndromes. J. Amer. Med. Assoc., 288 (4), 462-467.10.1001/jama.288.4.46212132976Search in Google Scholar

Johnston, J. A., Cluxton, R. J. Jr, Heaton, P. C., Guo, J. J., Moomaw, C. J., Eckman, M. H. (2003). Predictors of warfarin use among Ohio medic aid patients with new-onset nonvalvular atrial fibrillation. Arch. Intern. Med., 163 (14), 1705-1710.10.1001/archinte.163.14.170512885686Search in Google Scholar

Kimmel, S. E., Chen, Z., Price, M., Parker, C. S., Metlay, J. P., Christie, J. D., Brensinger, C. M., Newcomb, C. W., Samaha, F. F., Gross, R. (2007). The influence of patient compliance on anticoagulation control with warfarin: Results from the international normalized ratio compliance and genetics (IN-RANGE) study. Arch, Intern. Med., 167 (3), 229-235.10.1001/archinte.167.3.22917296877Search in Google Scholar

Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., Jeste, D. V. (2002). Prevalence of and risk factors for medication noncompliance in patients with schizophrenia: A comprehensive review of recent literature. J. Clin. Psychiatry, 63 (10), 892-909.10.4088/JCP.v63n1007Search in Google Scholar

Misdrahi, D., Llorca, P. M., Lancon, C., Bayle, F. J. (2002). Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications. Encephale, 28, 266-272.Search in Google Scholar

Okuno, J., Yanagi, H., Tomura, S. (2001). Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur. J. Clin. Pharmacol., 57 (8), 589-594.10.1007/s00228010034711758637Search in Google Scholar

Osterberg, L., Blaschke, T. (2005). Compliance to medication. New Engl. J. Med., 353 (5), 487-497.10.1056/NEJMra05010016079372Search in Google Scholar

Samsa, G., Matchar, D. B., Dolor, R. J., Wiklund, I., Hedner, E., Wygant, G., Hauch, O., Marple, C. B., Edwards, R. (2004). A new instrument for mea- suring anticoagulation-related quality of life: Development and preliminary validation. Health and Quality of Life Outcomes, 2, 22.10.1186/1477-7525-2-2242049115132746Search in Google Scholar

Sewitch, M. J., Abrahamowicz, M., Barkun, A., Bitton, A., Wild, G. E., Cohen, A., Dobkin, P. L. (2003). Patient noncompliance to medication in inflammatory bowel disease. Amer. J. Gastroenterol., 98 (7), 1535-1544.10.1111/j.1572-0241.2003.07522.x12873575Search in Google Scholar

Stilley, C. S., Sereika, S., Muldoon, M. F., Ryan, C. M., Dunbar-Jacob, J. (2004). Psychological and cognitive function: Predictors of compliance with cholesterol lowering treatment. Ann. Behav. Med., 27 (2), 117-124.10.1207/s15324796abm2702_615026295Search in Google Scholar

Urquhart, J. (2002). The odds of the three nons when an aptly prescribed medicine isn’t working: Non-compliance, non-absorption, non-response. Brit. J. Clin. Pharmacol., 54 (2), 212-220.10.1046/j.1365-2125.2002.01629.x187440012207644Search in Google Scholar

Van Servellen, G., Chang, B., Garcia, L., Lombardi, E. (2002). Individual and system level factors associated with treatment noncompliance in human immunodeficiency virus-infected men and women. AIDS Patient Care, 16 (6), 269-281.10.1089/1087291026006670512133262Search in Google Scholar

Van Walraven, C., Jennings, A., Oake, N., Fergusson, D., Forster, A. J. (2006). Effect of study setting on anticoagulation control: A systematic review and metaregression. Chest, 129 (5), 1155-1166.10.1378/chest.129.5.115516685005Search in Google Scholar